Author

H.J.E-V. Schmoll

Observed name: Hans-Jacchim Schmoll

Institutions: University Hospital in Halle, Martin Luther University Halle-Wittenberg

Observed institutions: University Hospital in Halle, Martin Luther University Halle-Wittenberg

OpenAlex ID: A5037158519

162P EO4010 (EO) + nivolumab (N) ± bevacizumab (B) in patients (pts) with microsatellite stable (MSS) metastatic colorectal carcinoma (mCRC)

2024 · R. Cohen, M.E. Elez Fernandez, et al. · Immuno-Oncology Technology · 1

825P Chronological changes in clinical outcomes of standard first-line oxaliplatin-based chemotherapy + targeted agents for metastatic colorectal cancer: Updated analysis of the ARCAD database

2025 · K. Yamamoto, H. Bando, et al. · Annals of Oncology

Response to Biologics in Patients With Early-Onset Treatment-Naïve Metastatic Colorectal Cancer—An Aide et Recherche en Cancérologie Digestive Database Analysis

2025 · Zhaohui Jin, Jesse G. Dixon, et al. · JCO oncology advances.

77P Chronologic improvement in survival of first-line oxaliplatin based chemotherapy + targeted therapy for metastatic colorectal cancer (mCRC): Analysis of the ARCAD database

2024 · Y. Takeda, K. Yamazaki, et al. · Annals of Oncology

317MO Efficacy of oxaliplatin-based adjuvant chemotherapy in older patients with stage III colon cancer: An ACCENT/IDEA pooled analysis of 12 trials

2022 · C. Gallois, Q. Shi, et al. · Annals of Oncology

Works count: 5

Citation count: 1

H-index: 1

I10-index: